Christopher L. Jordan
Consigliere Generale presso CHIMERIX, INC.
Posizioni attive di Christopher L. Jordan
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CHIMERIX, INC. | Consigliere Generale | 08/08/2022 | - |
Storia della carriera di Christopher L. Jordan
Precedenti posizioni note di Christopher L. Jordan
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ENDOCYTE, INC. | Consigliere Generale | - | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - | - |
| NOVARTIS AG | Consigliere Generale | - | - |
Formazione di Christopher L. Jordan
| George Washington University | Graduate Degree |
| Purdue University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
| Svizzera | 2 |
Posizioni
| General Counsel | 3 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| CHIMERIX, INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| Aziende private | 1 |
|---|---|
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
